BLKC
Price
$20.63Alerts
Change
-$0.63 (-2.96%)
Updated
Feb 23 closing price
Net Assets
4.15M
Intraday BUY SELL Signals
PYPL
Price
$59.48Alerts
Change
+$0.70 (+1.19%)
Updated
Nov 11 closing price
Capitalization
50.68B
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLKC vs PYPL

BLKC vs PYPL Comparison Chart in %
View a ticker or compare two or three
VS
BLKC vs. PYPL commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLKC is a Hold and PYPL is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PYPL with price predictions
Nov 10, 2026

Aroon Indicator for PYPL shows an upward move is likely

PYPL's Aroon Indicator triggered a bullish signal on November 10, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 212 similar instances where the Aroon Indicator showed a similar pattern. In 138 of the 212 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 65%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on PYPL as a result. In 59 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.

PYPL moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PYPL crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.

Following a +1.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where PYPL advanced for three days, in 190 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

Bearish Trend Analysis

The 10-day RSI Indicator for PYPL moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 20 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 65%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PYPL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

PYPL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 39 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. PYPL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.557) is normal, around the industry mean (3.902). P/E Ratio (11.114) is within average values for comparable stocks, (6.401). Projected Growth (PEG Ratio) (0.958) is also within normal values, averaging (3.918). Dividend Yield (0.009) settles around the average of (0.189) among similar stocks. P/S Ratio (1.428) is also within normal values, averaging (5.901).

The Tickeron PE Growth Rating for this company is 67 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PYPL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

FUNDAMENTALS RATINGS
PYPL: Fundamental Ratings
PYPL
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
39
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
67
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLKCPYPL
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
65%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
63%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
65%
Declines
ODDS (%)
N/A
Bearish Trend 17 days ago
73%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement

BLKC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLKC has been loosely correlated with SI. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BLKC jumps, then SI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLKC
1D Price
Change %
BLKC100%
N/A
SI - BLKC
43%
Loosely correlated
-0.05%
MSTR - BLKC
15%
Poorly correlated
+1.06%
TSM - BLKC
13%
Poorly correlated
+4.25%
PYPL - BLKC
13%
Poorly correlated
+1.19%
MARA - BLKC
13%
Poorly correlated
+4.36%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSCO37.500.10
+0.27%
Tractor Supply Co
EEIQ3.85-0.04
-1.03%
EpicQuest Education Group International Limited
WRBY29.90-0.31
-1.03%
Warby Parker
FLGT25.78-0.37
-1.41%
Fulgent Genetics
CHRS0.64-0.18
-21.61%
Coherus Oncology Inc